Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
How to Screen & Treat Depression in Patients with Cystic Fibrosis
The burden of poor mental health among CF patients is significant and impacts all aspects of disease management. Test yourself on international best practices for screening and treatment.
Rates of depression and anxiety among people with cystic fibrosis (CF) are known to be high. Prevalence of depression among children and adolescents ranges from ~8% to as high as 29% and among adults from 13% to 33%; prevalence of anxiety among adult CF patients has been found to range from 30% to 33%. Depression carries a risk for suicide and recent data from the Cystic Fibrosis Foundation Registry categorized 1.6% of recorded deaths as from suicide.
Related Content
